STERIS news

The WiseView Research desk's stories that name STERIS, the latest headlines about it, and the trades members of Congress and company insiders have disclosed. The STE page →

  • HeadlineSTERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026GlobeNewsWire · October 20, 2026 at 4:30 PM ET
  • HeadlineReasons to Add STE Stock to Your Portfolio Right NowZacks Investment Research · October 16, 2026 at 9:15 AM ET
  • HeadlineXodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)PRNewsWire · October 12, 2026 at 2:43 PM ET
  • HeadlineSteris to Acquire Xodus Medical for $2.1 BillionWSJ · October 12, 2026 at 9:11 AM ET
  • CongressRo Khanna bought $1,001 - $15,000 of STEHouse · D-California · traded Sep 11, 2026 · disclosed Oct 9, 2026
  • CongressRo Khanna sold $1,001 - $15,000 of STEHouse · D-California · traded Sep 25, 2026 · disclosed Oct 9, 2026
  • CongressKevin Hern sold $15,001 - $50,000 of STEHouse · R-Oklahoma · traded Sep 15, 2026 · disclosed Sep 28, 2026
  • CongressApril McClain Delaney sold $100,001 - $250,000 of STEHouse · D-Maryland · traded Aug 25, 2026 · disclosed Sep 10, 2026
  • CongressJared Moskowitz sold $1,001 - $15,000 of STEHouse · D-Florida · traded Jul 13, 2026 · disclosed Aug 28, 2026
  • CongressApril McClain Delaney sold $1,001 - $15,000 of STEHouse · D-Maryland · traded Jul 27, 2026 · disclosed Aug 4, 2026
  • CongressApril McClain Delaney sold $1,001 - $15,000 of STEHouse · D-Maryland · traded Jul 29, 2026 · disclosed Aug 4, 2026
  • CongressApril McClain Delaney sold $1,001 - $15,000 of STEHouse · D-Maryland · traded Jul 31, 2026 · disclosed Aug 4, 2026

Headlines link to their publishers. Members of Congress disclose ranges, not exact amounts, and may file weeks after the trade; insider filings are open-market purchases and sales from SEC Form 4. For information only, not investment advice.

Follow STE in the terminal.

Membership details

14-day free trial · no card needed · nothing to cancel.

Then $83/mo billed annually — $997 once a year.

WiseView provides market data and research tools for educational purposes. Nothing here is investment advice. Past performance does not predict future results.